Our News on Newswise

Newswise: Resized_Musser-Salazar-discuss-in-lab-168252_Plasma_photos_DSC01044.jpg

Study finds COVID-19 convalescent plasma therapy safe, with 76% patients improving

The first convalescent plasma transfusion trial results from Houston Methodist have been published. Of the study’s 25 patients, 19 have improved and 11 discharged. With no adverse side effects caused by the therapy, the study concluded...
7-Jun-2020 10:05 PM EDT Add to Favorites

Houston Methodist Psychologist shares his advice on managing COVID19-related stress and anxiety

COVID-19 has caused social isolation, a disruption in routine and a fear in many that they will catch the virus. This type of sudden change can induce stress and anxiety. However, Houston Methodist psychologist, William Orme, Ph.D., says there are...
27-May-2020 10:55 AM EDT Add to Favorites

Newswise: BloodDonorCenter.jpg

Study finds COVID plasma therapy safe, with 76% patients improving

The first convalescent plasma transfusion trial results from Houston Methodist have been released. Of the 25 patients in the study, 19 have improved and 11 have been discharged. With no adverse side effects caused by the therapy, the study concluded...
13-May-2020 12:05 PM EDT Add to Favorites

Houston Methodist researchers find telling clues in virus genes from COVID-19 patients

Houston Methodist released gene sequencing results from the first strains of the virus causing COVID-19 disease in Houston. Results reveal multiple introductions of SARS-CoV-2 into Houston followed by rapid community spread. No evidence was found of...
8-May-2020 2:40 PM EDT Add to Favorites

Investigational therapy gaining reputation as promising antiviral drug to fight COVID-19

COVID-19 patients in a clinical trial at Houston Methodist Hospital are responding quickly to the antiviral drug Remdesivir. Sponsored by Gilead Sciences, Houston Methodist was the fifth site in the U.S. to join the trials and the only trial site in...
17-Apr-2020 6:05 PM EDT Add to Favorites

Newswise: Plasma_photo_DrSalazar.jpg

Houston Methodist Ramps up Plasma Therapy as FDA Approves Clinical Trial

The FDA’s announcement Friday to approve convalescent serum therapy as a large-scale clinical trial opened the door for more patients to receive the potentially life-saving gift of a donor’s plasma.
4-Apr-2020 1:40 PM EDT Add to Favorites

Newswise: April 2020 Science Advances-H. Shen-Image.jpg

Fatty acid in triglycerides proves an effective platform for biological drug delivery

Houston Methodist nanomedicine researchers are studying a new drug delivery system that transports oral medication via triglycerides that could eliminate the need for injections or IV treatments of some biologic drugs for rheumatoid arthritis and...
2-Apr-2020 8:30 AM EDT Add to Favorites

Newswise: BloodDonorCenter.jpg

FDA Approves First Plasma Therapy for Houston Methodist COVID-19 Patient

Houston Methodist received FDA approval Saturday to become the first academic medical center in the nation to transfuse donated plasma from a recovered COVID-19 patient into a critically ill patient. This treatment was fast-tracked to the bedside...
30-Mar-2020 8:30 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: geyer-charles-1891795001.jpg

Houston Methodist oncologist available to comment on NCI model predicting 10,000 additional breast/colorectal cancer deaths due to COVID-19

24-Jun-2020 10:10 AM EDT

Newswise: DrMassud-HMAC-SM.jpg

Research and innovation as an essential function amid the COVID-19 pandemic

Necessity being the mother of invention, Houston Methodist clinicians, researchers and staff have collaborated on a number of clinical device and research innovations in response to COVID-19. Houston Methodist Academic Institute leadership has...
29-Apr-2020 12:10 PM EDT

Newswise: KashBita.jpg

Bita Kash, PhD, Researcher with Houston Methodist, available to discuss COVID-19 and African American communities

20-Apr-2020 2:30 PM EDT

Newswise: mcculloch09.2013photo5brown2.jpg

Orthopedic surgeon available to discuss pectoral injuries in professional athletes

8-Jan-2020 3:00 PM EST

Early and Unusual Flu Season a Risk for Persons Who Vape, Have Chronic Disease, More

10-Dec-2019 4:05 PM EST

How to avoid holiday headaches

Six tips for avoiding holiday headache triggers from Houston Methodist neurologist Bing Liao, M.D., M.Sc.
21-Nov-2019 12:05 PM EST

Embarrassing symptoms prevent relief of treatable conditions

Nearly 25% of women live with treatable conditions known as pelvic floor disorders, but there is one main reason why the vast majority of them will not seek treatment: they are too embarrassed to talk about it.
20-Nov-2019 11:20 AM EST

Three tips for better sleep

More than one-third of Americans get less than seven hours of sleep each night, putting them at risk for serious, chronic health conditions such as diabetes, heart disease and obesity. The real victim of a lack of sleep, however, is the brain.
29-Oct-2019 2:15 PM EDT

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

U.S. News & World Report has named Houston Methodist Hospital the No. 1 hospital in Texas and among the top 20 hospitals in the nation. Houston Methodist's reputation for outstanding care, treatments and research attracts patients from Texas, the nation and around the world.

Our teams of surgeons, physicians, researchers and other experts collaborate to solve medicine’s biggest challenges and turn discoveries into new therapies and treatments. Our drive for innovation is rooted in the legacy created by world-renowned cardiac surgeon Dr. Michael E. DeBakey. He performed the first coronary artery bypass surgery in Texas, and pioneered surgical advances, which have become universal practices.

These days, Houston Methodist not only is well established as a leader in heart and vascular treatments, research and education based on DeBakey’s achievements and reputation, but also is known for spearheading breakthroughs in organ transplantation, orthopedics, cancer treatment and neurology and neuroscience.

Experts

Contacts

Stefanie Asin
Public Relations Director
Corporate Communications

SLAsin@houstonmethodist.org

832-667-5809

Gale Smith
Public Relations Manager
Research Institute, Gastroenterology & GI Surgery, Ophthalmology, Otolaryngology/ENT

GSmith@houstonmethodist.org

832-667-5843

Lisa Merkl
Medical Research Editor, PR Office
Research Institute

lmerkl@houstonmethodist.org

832-667-5916

Ashley White
Senior Media Relations Specialist
Cancer Center, Orthopedics & Sports Medicine

aewhite2@houstonmethodist.org

8326675849

Patti Muck
Senior Media Relations Coordinator
Neurological Institute, Women’s Health (OB/GYN)

pamuck@houstonmethodist.org

832-667-5741

Twitter

close
3.9795